VC005 tablets: Clinical Trials

2 trials of VC005 tablets, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow VC005 tablets: new trials by email Literature Review of VC005 tablets trials Research Report on VC005 tablets

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
VC005 tablets, VC005 Tablets Placebo - Moderate to Severe Atopic Dermatitis
Phase 2CompletedJiangsu vcare pharmaceutical technology co., LTD1492023-07-202024-07-29
Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
VC005 tablets, Tofacitinib Citrate Tablets, VC005 Tablets Placebo - Active Ankylosing Spondylitis
Phase 2CompletedJiangsu vcare pharmaceutical technology co., LTD1802023-04-262024-07-29

Sponsors

Jiangsu vcare pharmaceutical technology co., LTD (2)

Countries

China (2)

Top investigators

Qianjin Lu (1)  ·  Xu Liu (1)  ·  Zhanguo Li (1)